PCVX sells 21.6M* shares @$32.00—a 3% discount to Monday’s close—raising ~$650M* in net proceeds https://www.globenewswire.com/news-release/2022/10/26/2541446/0/en/Vaxcyte-Announces-Pricing-of-600-Million-Public-Offering.html *Assuming exercise of underwriter’s option.